Your browser doesn't support javascript.
loading
Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart Study.
Januzzi, James L; Lyass, Asya; Liu, Yuyin; Gaggin, Hanna; Trebnick, April; Maisel, Alan S; D'Agostino, Ralph B; Wang, Thomas J; Massaro, Joseph; Vasan, Ramachandran S.
Afiliação
  • Januzzi JL; From the Framingham Heart Study, MA (J.L.J., A.L., H.G., R.B.D.A., T.J.W., J.M., R.S.V.); Cardiology Division, Massachusetts General Hospital, Boston (J.L.J., H.G.); Departments of Cardiometabolic Trials (J.L.J, H.G., A.T.) and Biostatistics (A.L., Y.L., R.B.D., J.M.), Harvard Clinical Research Inst
  • Lyass A; From the Framingham Heart Study, MA (J.L.J., A.L., H.G., R.B.D.A., T.J.W., J.M., R.S.V.); Cardiology Division, Massachusetts General Hospital, Boston (J.L.J., H.G.); Departments of Cardiometabolic Trials (J.L.J, H.G., A.T.) and Biostatistics (A.L., Y.L., R.B.D., J.M.), Harvard Clinical Research Inst
  • Liu Y; From the Framingham Heart Study, MA (J.L.J., A.L., H.G., R.B.D.A., T.J.W., J.M., R.S.V.); Cardiology Division, Massachusetts General Hospital, Boston (J.L.J., H.G.); Departments of Cardiometabolic Trials (J.L.J, H.G., A.T.) and Biostatistics (A.L., Y.L., R.B.D., J.M.), Harvard Clinical Research Inst
  • Gaggin H; From the Framingham Heart Study, MA (J.L.J., A.L., H.G., R.B.D.A., T.J.W., J.M., R.S.V.); Cardiology Division, Massachusetts General Hospital, Boston (J.L.J., H.G.); Departments of Cardiometabolic Trials (J.L.J, H.G., A.T.) and Biostatistics (A.L., Y.L., R.B.D., J.M.), Harvard Clinical Research Inst
  • Trebnick A; From the Framingham Heart Study, MA (J.L.J., A.L., H.G., R.B.D.A., T.J.W., J.M., R.S.V.); Cardiology Division, Massachusetts General Hospital, Boston (J.L.J., H.G.); Departments of Cardiometabolic Trials (J.L.J, H.G., A.T.) and Biostatistics (A.L., Y.L., R.B.D., J.M.), Harvard Clinical Research Inst
  • Maisel AS; From the Framingham Heart Study, MA (J.L.J., A.L., H.G., R.B.D.A., T.J.W., J.M., R.S.V.); Cardiology Division, Massachusetts General Hospital, Boston (J.L.J., H.G.); Departments of Cardiometabolic Trials (J.L.J, H.G., A.T.) and Biostatistics (A.L., Y.L., R.B.D., J.M.), Harvard Clinical Research Inst
  • D'Agostino RB; From the Framingham Heart Study, MA (J.L.J., A.L., H.G., R.B.D.A., T.J.W., J.M., R.S.V.); Cardiology Division, Massachusetts General Hospital, Boston (J.L.J., H.G.); Departments of Cardiometabolic Trials (J.L.J, H.G., A.T.) and Biostatistics (A.L., Y.L., R.B.D., J.M.), Harvard Clinical Research Inst
  • Wang TJ; From the Framingham Heart Study, MA (J.L.J., A.L., H.G., R.B.D.A., T.J.W., J.M., R.S.V.); Cardiology Division, Massachusetts General Hospital, Boston (J.L.J., H.G.); Departments of Cardiometabolic Trials (J.L.J, H.G., A.T.) and Biostatistics (A.L., Y.L., R.B.D., J.M.), Harvard Clinical Research Inst
  • Massaro J; From the Framingham Heart Study, MA (J.L.J., A.L., H.G., R.B.D.A., T.J.W., J.M., R.S.V.); Cardiology Division, Massachusetts General Hospital, Boston (J.L.J., H.G.); Departments of Cardiometabolic Trials (J.L.J, H.G., A.T.) and Biostatistics (A.L., Y.L., R.B.D., J.M.), Harvard Clinical Research Inst
  • Vasan RS; From the Framingham Heart Study, MA (J.L.J., A.L., H.G., R.B.D.A., T.J.W., J.M., R.S.V.); Cardiology Division, Massachusetts General Hospital, Boston (J.L.J., H.G.); Departments of Cardiometabolic Trials (J.L.J, H.G., A.T.) and Biostatistics (A.L., Y.L., R.B.D., J.M.), Harvard Clinical Research Inst
Arterioscler Thromb Vasc Biol ; 36(8): 1692-7, 2016 08.
Article em En | MEDLINE | ID: mdl-27312221
ABSTRACT

OBJECTIVE:

Neurotensin is a peptide whose receptor (sortilin receptor 1) is linked to cardiovascular disease (CVD) development. We hypothesized concentrations of proneurotensin (stable profragment of neurotensin) would predict incident cardiovascular events in community-based subjects. APPROACH AND

RESULTS:

Blood samples from 3439 participants in the Framingham Heart Study (FHS) Offspring cohort (mean age 59.2 years, 47.1% male) were tested for proneurotensin. Primary outcome of interest was incident hard CVD (myocardial infarction, stroke, and cardiovascular death); interaction between proneurotensin concentration with sex, low-density lipoprotein concentrations, and sortilin receptor 1 single-nucleotide polymorphisms was sought. At baseline, those in the highest log-proneurotensin quartile were younger and heavier (P<0.001); across proneurotensin quartiles, more prevalent hard CVD (from 3% to 7%; P<0.001) and diabetes mellitus (from 6% to 14%; P<0.001) were present. In age- and sex-adjusted models, log-proneurotensin concentrations predicted incident hard CVD (hazard ratio [HR], 1.24 per SD change in log-proneurotensin; 95% confidence intervals [CIs], 1.11-1.39; P<0.001), a finding that remained on adjustment for standard CVD risk factors (HR, 1.13; 95% CI, 1.01-1.27; P=0.03). Elevated log-proneurotensin concentrations were associated with shorter time to first event (P=0.02). We found no effect modification by sex, low-density lipoprotein concentration, or sortilin receptor 1 single-nucleotide polymorphisms. Concentrations of proneurotensin were modestly associated with left ventricular mass and coronary artery calcium in these subjects.

CONCLUSIONS:

Higher concentrations of proneurotensin are associated with a greater risk of incident cardiovascular events in the community. This association did not vary according to sex, baseline low-density lipoprotein, or sortilin receptor 1 genotype.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Precursores de Proteínas / Neurotensina / Doenças Cardiovasculares Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Precursores de Proteínas / Neurotensina / Doenças Cardiovasculares Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2016 Tipo de documento: Article